• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

HS Hyosung's Growth Gamble Backfires as Debt Fears Resurface

곽호룡 기자

horr@fntimes.com

기사입력 : 2026-07-13 09:01 최종수정 : 2026-07-20 10:36

◇ Steps Down From Holding Company to Join Advanced Materials Directly
◇ Market Reacts Coldly to Decision to Halt Asset Sale
◇ Total Borrowings at KRW 2.5 Trillion Raise Financial Burden Concerns

This infographic, originally published by Korea Financial Times, has been reconstructed using generative AI.

This infographic, originally published by Korea Financial Times, has been reconstructed using generative AI.

이미지 확대보기
[Korea Financial Times, Gwak Horyung] HS Hyosung Vice Chairman Cho Hyun-sang, who took direct charge of managing HS Hyosung Advanced Materials, now finds his high-stakes bet at a crossroads. Cho chose "growth" over securing cash through the sale of low-margin business units, but the market's reaction has been cold.

HS Hyosung Advanced Materials shares have fallen 15% since the start of the year.

In particular, the stock plunged 47% in just two months, from its yearly high of KRW 277,500 on April 29 to KRW 148,300 on July 9. Even as expectations grow for an industry rebound this year, why has the stock performed so poorly?

HS Hyosung was established in 2022 as the entity through which Vice Chairman Cho Hyun-sang, younger brother of Hyosung Group Chairman Cho Hyun-joon, built a genuinely independent management structure. HS Hyosung Advanced Materials — which operates industrial materials businesses including tire reinforcement materials, industrial yarn, aramid, and carbon fiber — serves as the pillar subsidiary of HS Hyosung Group. Although the holding company owns only a 30% stake, the unit accounts for 67% of the group's consolidated revenue.

Owner-manager Vice Chairman Cho Hyun-sang abruptly joined HS Hyosung Advanced Materials as an in-house director this past March. At the same time, he stepped down as CEO of the holding company. The move was interpreted as a sign of his determination to personally oversee HS Hyosung Advanced Materials and focus on the business.

Since Cho's arrival, the company's new business strategy has shifted. Previously, the company had acquired EMM, the Belgian silicon anode material subsidiary of Umicore, for KRW 200 billion last November. It also announced a massive investment plan to inject KRW 1.5 trillion over five years to enter the silicon anode material market — a key next-generation battery material.

To raise cash, the company had also been pursuing the sale of its tire steel cord business. However, in April, HS Hyosung Advanced Materials disclosed that it had notified private equity firm Bain Capital — with which it had been negotiating the sale — that it was withdrawing from the deal, adding that it had no plans to pursue further sale procedures.

The company cited a "surge in demand" and the need for a "stable supply chain" as the reasons for withdrawing the sale. It explained that tire customers had requested a stable supply chain following the outbreak of the U.S.-Iran war on February 28. Concerns over raw material price spikes and supply disruptions also pushed up overall product selling prices.

However, from late April — when the Middle East conflict entered a lull — HS Hyosung Advanced Materials shares began a sharp decline. This is attributed to renewed concerns over the financial burden, which had been one of the reasons behind the steel cord sale plan in the first place.

The company's financial burden has grown since 2023, when it began ramping up expansion of its carbon fiber plants. According to THE COMPASS, Korea Financial Times' proprietary AI data platform, HS Hyosung Advanced Materials' net debt has continued to rise, from KRW 1.607 trillion in 2022 to KRW 2.5307 trillion as of the end of the first quarter of 2026.

This has resulted in annual interest expenses of KRW 80–90 billion. Because operating cash flow has fallen short of capital expenditures, free cash flow (FCF) has been negative for four consecutive years since 2023.

Concerns are also mounting that the financial burden could intensify further as large-scale investment proceeds for the company's new secondary battery materials business. In effect, financial fatigue is accumulating from a new large-scale investment even before the carbon fiber investment has fully borne fruit.

The key question is whether the company can demonstrate its ability to handle additional investment. The company's operating profit this year is expected to rise more than 30% year-on-year to around KRW 200 billion — a level sufficient to cover roughly KRW 300 billion in annual investment. However, analysts note that to generate meaningful cash flow and ease the current financial burden, the company would need to post annual operating profit in the mid-KRW 300 billion range or higher for several years to come.

Securities firms project the company's 2027 operating profit at around KRW 250 billion. While profitability is improving, given the downward pressure on margins from Chinese capacity-expansion competition in the advanced materials sector, easing the financial burden in the near term is unlikely to be easy.

Gwak Horyung (horr@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 Kia's Three Growth Engines Fuel Its Historic Charge Toward No. 1 The long-standing formula of South Korea's auto market — Hyundai Motor No. 1, Kia No. 2 — is showing cracks. Kia has narrowed the sales gap with Hyundai Motor to within striking distance, and forecasts that it will claim the top spot in domestic sales for the first time in its history this year are increasingly becoming reality.Kia's sales momentum is attributed to solid performance in its core SUV lineup, combined with the successful rollout of new lineups such as mass-market electric vehicle (EV) models and purpose-built vehicles (PBVs).According to Kia's disclosure on the 28th, the compan 2 SK Biopharmaceuticals Doubles Down: $795M Bet on Second Blockbuster Epilepsy Drug "SK Biopharmaceuticals has now entered a different league, one in which we compete directly with global big pharma companies in the United States and Europe, not just in Korea."President Lee Dong-hoon of SK Biopharmaceuticals made this declaration at a press conference held on the afternoon of the 26th at the Westin Josun Hotel in Jung-gu, Seoul, where he abruptly unveiled the company's license-in (L/I) agreement to acquire opakalim, an epilepsy drug candidate from Ireland-based Biohaven.Through the deal, SK Biopharmaceuticals aims to reduce its reliance on a single product — cenobamate — an 3 Naver Bets on AI Infrastructure While Kakao Bets on Agentic AI South Korea's two leading platform companies, Naver and Kakao, are maintaining similar levels of research and development (R&D) investment relative to revenue in the first half of this year, but they are pursuing markedly different strategies to secure AI competitiveness.Naver is focused on expanding AI infrastructure, while Kakao — taking its spinoff as an opportunity — is concentrating on strengthening agentic AI services.According to the Financial Supervisory Service's electronic disclosure system on the 24th, Naver's and Kakao's R&D spending in the first half of 2026 came to KRW
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략
[그래픽 뉴스] 퇴근 후 주차했는데 수익 발생? V2G의 정체

FT도서

더보기